Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 6/20/2011 10:53:32 AM : Outperform Start Price: $4.98 ACUR Score: -48.39

fda approval

Report this Post Reply

Featured Broker Partners


Advertisement